Prolongation of the serum half-life period of superoxide dismutase by poly(ethylene glycol) modification

Journal of Controlled Release

Volumn 46, Issue 3, 1997, Pages 253-261

  Nakaoka, Ryusuke ^a   Tabata, Yasuhiko ^a   Yamaoka, Tetsuji ^a   Ikada, Yoshito ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Body distribution; Chemical modification; Poly(ethylene glycol); Protein; Serum half life period

Indexed keywords

MACROGOL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY DISTRIBUTION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG TISSUE LEVEL; ENZYME MODIFICATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; KIDNEY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030894641     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01605-7     Document Type: Article

References (33)

1. A. Abuchowski, T. van Es, N.C. Palczuk and F.F. Davis, Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. 252 (1977) 3578-3581.
2. A. Abuchowski, J.R. McCoy, N.C. Palczuk, T. van Es and F.F. Davis, Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 252 (1977) 3582-3586.
3. A. Matsushima, H. Nishimura, Y. Ashihara, Y. Yokota and Y. Inada, Modification of E. coli asparaginase with 2,4-bis(o-methoxypolyethylene glycol)-6-chloro-s-triazine (activated PEG2); disappearance of binding ability towards anti-serum and retention of enzymic activity. Chem. Lett. (1980) 773-776.
4. H. Nishimura, K. Takahashi, K. Sakurai, K. Fujinuma, Y. Inamura, M. Ooba and Y. Inada, Modification of batroxobin with activated polyethylene glycol: reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs. Life Sci. 33 (1983) 1467-1473.
5. T. Yoshimoto, H. Nishimura, Y. Saito, K. Sakurai, Y. Kamisaki, H. Wada, M. Sako, G. Tsujino and Y. Inada, Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia. Jpn. J. Cancer Res. (Gann) 77 (1986) 1264-1270.
6. N. Sakuragawa, K. Shimizu, K. Kondo, S. Kondo and M. Niwa, Studies on the effect of PEG-modified urokinase on coagulation-fibrinolysis using beagles. Thromb. Res. 41 (1986) 627-635.
7. K. Miyata, Y. Nakagawa, M. Nakamura, T. Ito, K. Sugo, T. Fujita and K. Tomoda, Altered properties of serratia superoxide dismutase by chemical modification. Agric. Biol. Chem. 52 (1988) 1575-1581.
8. J.S. Beckman, R.L. Minor Jr., C.W. White, J.E. Repine, G.M. Rosen and B.A. Freeman, Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J. Biol. Chem. 263 (1988) 6884-6892.
9. K. Yoshinaga and J.M. Harris, Effect of coupling chemistry on the activity of poly(ethylene glycol)-modified alkaline phosphatase. J. Bioact. Compat. Polym. 4 (1989) 17-24.
10. S. Nagae, T. Matsuda and T. Akutsu, Development of coupling agent with long-chain hydrophilic spacer: application to protein modification. Jpn. J. Artif. Organs 18 (1989) 137-140.
11. F.M. Veronese, P. Caliceti, A. Pastorino, O. Schiavon and L. Sartore, Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase. J. Control. Release 10 (1989) 145-154.
12. K. Kitamura, T. Takahashi, K. Takashina, T. Yamaguchi, A. Noguchi, H. Tsurumi, T. Toyokuni and S. Hakomori, Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localization. Biochem. Biophys. Res. Commun. 171 (1990) 1387-1394.
13. F. Fuertges and A. Abuchowski, The clinical efficacy of poly(ethylene glycol)-modified proteins. J. Control. Release 11 (1990) 139-148.
14. N.V. Katre, Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol. J. Immunol. 144 (1990) 209-213.
15. F.J. Meyers, C. Paradise, S.A. Scudder, G. Goodman and M. Konrad, A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2. Clin. Pharmacol. Ther. 49 (1991) 307-313.
16. H. Teppler, G. Kaplan, K.A. Smith, A.L. Montana, P. Meyn and Z.A. Cohn, Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J. Exp. Med. 177 (1993) 483-492.
17. A.W. Richter and E. Åkerblom, Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified protein. Int. Arch. Allergy Appl. Immunol. 70 (1983) 124-131.
18. A.H. Sehon, Suppression of antibody responses by conjugates of antigens and monomethoxypoly(ethylene glycol). Adv. Drug Deliv. Rev. 6 (1991) 203-217.
19. Y. Takakura, T. Fujita, M. Hashida and H. Sezaki, Disposition characteristics of macromolecules in tumor-bearing mice. Pharm. Res. 7 (1990) 339-346.
20. J.A. Nagy, K.T. Herzberg, E.M. Masse, G.P. Zientara and H.F. Dvorak, Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. Cancer Res. 49 (1989) 5448-5458.
21. T. Yamaoka, Y. Tabata and Y. Ikada, Blood clearance and organ distribution of intravenously administered polystyrene microspheres of different sizes. J. Bioact. Compat. Polym. 8 (1993) 220-235.
22. T. Yamaoka, Y. Tabata and Y. Ikada, Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. J. Pharm. Sci. 83 (1994) 601-606.
23. T. Yamaoka, Y. Tabata and Y. Ikada, Comparison of body distribution of poly(vinyl alcohol) with other water-soluble polymers after intravenous administration. J. Pharm. Pharmacol. 47 (1995) 479-486.
24. M. Leonard, J. Neel and E. Dellacherie, Synthesis of monomethoxypolyoxethylene-bound haemoglobins. Tetrahedron 40 (1984) 1581-1584.
25. A.F.S.A. Habeeb, Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal. Biochem. 14 (1966) 328-336.
26. 125I-labeled human growth hormone of high specific radioactivity. Biochem. J. 89 (1963) 114-123.
27. K. Yamaoka, Y. Tanigawa, T. Nakagawa and T. Uno, A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharm. Dyn. 4 (1981) 879-885.
28. Y. Tsutsumi, T. Kihara, S. Tsunoda, T. Kanamori, S. Nakagawa and T. Mayumi, Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency. Br. J. Cancer 71 (1995) 963-968.
29. B.M. Brenner, T.H. Hostetter and H.D. Humes, Glomerular permselectivity: barrier function based on discrimination of molecular size and charge. Am. J. Physiol. 234 (1978) F455-F460.
30. M.A. Venkatachalam and H.G. Rennke, The structural and molecular basis of glomerular filtration. Circ. Res. 43 (1978) 337-347.
31. T. Maack, V. Johnson, S.T. Kau, J. Figueiredo and D. Sigulem, Renal filtration, transport, and metabolism of low-molecular-weight proteins. Kidney Int. 16 (1979) 251-270.
32. P.J. Flory, Principles of Polymer Chemistry, Cornell Univ. Press, Ithaca, New York, 1953.
33. Z. Ota, H. Makino, Y. Takaya and T. Ofuji, Molecular sieve in renal glomerular and tubular basement membranes as revealed by electron microscopy. Renal. Physiol. 3 (1980) 317-323.